buteyko breath works
HomeWhat can Buteyko do for you?Buteyko..from Russia with LoveAbout buteyko breath worksButeyko in the MediaButeyko Clinical TrialsButeyko Institute Method CoursesButeyko ProductsTestimonialsRelated NewsContact UsDownload
Buteyko Clinical Trials

 Why All the Excitement About Clinical Trials?

Clinical Trials have been used by Medical Professionals and Researchers to evaluate the usefulness of the Buteyko Method  in reducing Reliever Use &  Preventer Use. All had positive results.

Six Clinical Trials Show Big Reductions in Preventer Use

People are concerned with the dangers of long term steroid use. Trials reported in 6 countries since 1998 show that, on average, Buteyko reduced the  use of steroid preventers by more than half (i.e. 52%).  This was a very significant drop in steroid use.

webassets/j0433106.jpg

2006 Canadian Trial ..... Buteyko  Results Delight Doctors

"I've been astonished and also very pleased with the excellent result.  (Due to Buteyko):  There is no disruption of their life at all by their disease. Normal activities; not waking at night; not needing to use any reliever medications.  It (Buteyko) is just great.  The neat thing about it is that it has no side effects.  It's very safe."

Dr. Robert Cowie, Chief Respirologist/ Chief Investigator of the 2006 clinical trial,  Foothills Hospital, Alberta, Calgary. 

Huge Decreases in Reliever Use 

UK clinical trial in Nottingham found that the Buteyko Method reduced Reliever use by 100%. The average decrease over a total of six trials was a huge 89%.

Living Symptom Free

All six trials showed that learning and practicing the Butyeko Method allowed participants to  live with very little need for their asthma relievers.  This is great news for those who want to avoid the potential complications and health issues of reliever use.

The Gisborne Trials..... Kids Really Get Something to Shout About

These trials focused on children. The results were the same as with adults i.e. big reductions in both Preventer and Reliever use.

 

webassets/j0439297.jpg

Buteyko Clinical Trials - Result Summary

Calgary, Alberta, Canada 

 

Results after applying Buteyko techniques for 6 months

  • Asthma control improved from 41% to 75%
  • Preventer Use - median reduction 39%
  • Preventer use - elimination of 21%
 

Respiratory Medicine 2008, doi:10.1016/j.rmed.2007.12.012  R.L.Cowie, et al.

Glasgow, UK

 

Asthma symptoms decreased by an average of 98%

Use of reliever inhalers decreased by an average of 98%

Use of preventor inhalers decreased by an average of 92%

Instance of cold or flu decreased by an average of 20%

 

British Thoracic Society Press Release 4th Dec. 2003

 

Sydney, Australia

 

Results after applying Buteyko techniques for 12 weeks

  • Reliever use - median reduction of 86%
  • Preventer use - median reduction of 50%
 

Thorax Journal 2006;61:651-656   C.A.Slader, et al.

Gisborne, New Zealand

 

Results after applying Buteyko Techniques to children with asthma for 12 weeks

  • Reliever use - median reduction of 66%
  • Preventer use - median reduction of 41%
  • Prednisone use - 11 courses given 3 months before the trial
  • Prednison - 1 course given 3 months after the trial
 

New Zealand Medical Journal May 2006 Vol 119 No. 1234 ISSN1175 8716   P.McHugh, et al. 

Nottingham, England

 

Results after applying Buteyko techniques

  • Reliever use - Reduction 100%
  • Preventer use - median reduction 41.5%
 

Thorax 2003;58:674-679  S. Cooper, et al.

Gisborne, New Zealand

 

Results after applying Buteyko techniques to children with asthma for 12 weeks.

  • Reliever use - median reduction of 85%
  • Preventer use - median reduction of 50%
 

New Zealand Medical Journal 2002;  Vol 116 No 1187 ISSN 1175 8716 P. McHugh, et al. 

Brisbane, Australia

 

Results after applying Buteyko Techniques for 12 weeks

  • Reliever use - median reduction of 96%
  • Preventer use - median reduction of 49%
  • Minute volume - median reduction of 32%
 

Medical Journal of Australia 1998; 169:575-578  S.D.Bowler, et al. 

Back to the Top

Enter supporting content here